<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <title>Vancomycin Dosing References</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
</head>
<body class="prose max-w-3xl mx-auto p-6">
  <h1>References for Vancomycin Dosing</h1>
  <p>Key guidance and formulas implemented in this application:</p>
  <ul>
    <li>AUC/MIC target: Maintain daily AUC between 400–600 mg·h/L (assuming MIC=1 mg/L) per the 2020 ASHP/IDSA/PIDS/SIDP consensus guideline. Exposures above 800 mg·h/L increase nephrotoxicity risk.</li>
    <li>When AUC monitoring is unavailable, trough concentrations of 15–20 mg/L can be used as a surrogate to achieve AUC/MIC ≥400.</li>
    <li>Dosing based on actual body weight: Loading 20–25 mg/kg for serious infections; maintenance 15–20 mg/kg. Round doses to the nearest 250 mg. Avoid total daily doses ≥100 mg/kg.</li>
    <li>Interval by creatinine clearance (CrCl): q8h if CrCl ≥100 mL/min, q12h if 60–100 mL/min, q24h if &lt;60 mL/min.</li>
    <li>Pharmacokinetic approximations: ke ≈ 0.00083 × CrCl + 0.0044 (h⁻¹); Vd ≈ 0.7 L/kg × weight. Use first-order elimination to compute half-life and AUC.</li>
  </ul>
  <h2>Primary Source</h2>
  <p>
    Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious Methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. 2020.
    <br />
    <a href="https://www.ashp.org/Drug-Shortages/Current-Shortages/Vancomycin-Therapeutic-Monitoring">ASHP/IDSA Consensus Guideline</a>
  </p>
</body>
</html>
